Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank69
3Y CAGR-22.1%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-22.1%/yr
Quarterly compound
Percentile
P69
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 10.59% |
| Q2 2025 | -30.05% |
| Q1 2025 | -33.32% |
| Q4 2024 | -6.09% |
| Q3 2024 | -36.62% |
| Q2 2024 | 48.85% |
| Q1 2024 | 11.65% |
| Q4 2023 | -22.79% |
| Q3 2023 | 22.76% |
| Q2 2023 | 9.75% |
| Q1 2023 | 17.45% |
| Q4 2022 | -12.13% |
| Q3 2022 | 22.36% |
| Q2 2022 | -2.07% |
| Q1 2022 | -4.97% |
| Q4 2021 | -18.13% |
| Q3 2021 | -35.49% |
| Q2 2021 | -19.21% |
| Q1 2021 | 45.47% |
| Q4 2020 | -243.80% |
| Q3 2020 | -28.21% |
| Q2 2020 | 44.59% |
| Q1 2020 | -1.16% |
| Q4 2019 | 17.26% |
| Q3 2019 | -22.40% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |